Silverman Joshua 4

What Happened

• Joshua Silverman, a director of Petros Pharmaceuticals, was granted 4,375,000 restricted shares (transaction code A) on 2026-06-05. The shares were acquired at $0.00 per share (total cash paid $0), reflecting a compensation award rather than a market purchase.

Key Details

• Transaction date: 2026-06-05; Price: $0.00 per share; Shares granted: 4,375,000.
• Vesting: 50% vested on the grant date; the remaining 50% vests on the six‑month anniversary, subject to continued service (per footnote).
• Shares owned after the transaction: not specified in the filing.
• Filing timeliness: filing covers the transaction date and was filed the same day (no late filing indicated).
• Transaction type: Award/Grant (Form 4 code A). No tax‑withholding or sale reported in this filing.

Context

• This is an equity compensation award (restricted stock) tied to service; it is not a market purchase or sale. Such grants are commonly used for compensation and retention and do not by themselves signal insider buying or selling activity.